Pfizer Canada has introduced Toviaz (fesoterodine fumarate extended release tablets) that is indicated for the treatment of patients with overactive bladder (OAB) with symptoms of urinary frequency, urgency, or urge incontinence, or any ...
Tags: Pfizer Canada, Toviaz, overactive bladder, OAB
Edgemont Pharmaceuticals has launched a new formulation dose of bupropion extended-release tablets in a strength of 450mg dose. The Forfivo XL, which the company claims, is the only available 450mg dose of an extended-release bupropion ...
Mylan Pharmaceuticals has received final FDA approval for its abbreviated new drug application (ANDA) for Lithium Carbonate Extended-release tablets USP, 300mg. Mylan has announced immediate shipment of the generic version of Noven ...
Tags: new drug, Lithium Carbonate Extended-release tablets USP, manic episodes
Dr. Reddy's Laboratories, an integrated pharmaceutical company, has introduced Ropinirole Hydrochloride XR (extended-release) tablets of strengths 2mg, 4mg, 6mg, 8mg, and 12mg. The launch was followed by the approval of Dr. Reddy's ANDA ...
Tags: Generic Requip Xl Tablets, REQUIP XL tablets, pharmaceutical
Janssen Pharmaceuticals has signed a licensing deal with Depomed for its Acuform gastric retentive drug delivery technology. As per the agreement, Janssen gained non-exclusive license and other rights to certain Acuform patents and in ...
Tags: Janssen Pharmaceuticals, Acuform Patents, drug delivery technology
Wockhardt has received final approval from the US Food and Drug Administration ((FDA) to market extended-release tablets containing 2.5mg, 5mg and 10mg Felodipine, which are used to treat hypertension. Felodipine is the generic name for ...
Astellas Pharma and XenoPort have announced the introduction of Regnite (gabapentin enacarbil) extended-release tablets in Japan for the treatment of moderate-to-severe primary restless legs syndrome (RLS). Regnite, which was discovered ...
Tags: Rls Drug, Restless legs syndrome, Regnite extended-release tablets
Wockhardt, a pharmaceutical and biotechnology company, has received final FDA approval for marketing 100mg, 150mg and 200mg 12 hour extended release tablets of Bupropion HCl indicated for depression. Wockhardt has announced the immediate ...
Watson Pharmaceuticals has introduced an authorized generic version of Fortamet as a part of an agreement with Shionogi. The company began the shipment of generic Fortamet (metformin hydrochloride extended-release tablets). Fortamet is ...
Tags: Fortamet, blood glucose, Generic Version
Qualitest Pharmaceuticals, a generic pharmaceutical company, has won the US Food and Drug Administration (FDA) approval for abbreviated new drug application (ANDA) for Levetiracetam extended-release tablets, 500mg and 750mg. The ...
Astellas Pharma has gained FDA approval for Myrbetriq (mirabegron) extended-release tablets for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and urinary frequency. Myrbetriq is a once ...
Tags: FDA approval, pharmaceutical product, oral OAB treatment